Mona Kargar

490 total citations
32 papers, 364 citations indexed

About

Mona Kargar is a scholar working on Psychiatry and Mental health, Epidemiology and Clinical Psychology. According to data from OpenAlex, Mona Kargar has authored 32 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Epidemiology and 4 papers in Clinical Psychology. Recurrent topics in Mona Kargar's work include Pharmaceutical Practices and Patient Outcomes (3 papers), Electroconvulsive Therapy Studies (3 papers) and Nail Diseases and Treatments (2 papers). Mona Kargar is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (3 papers), Electroconvulsive Therapy Studies (3 papers) and Nail Diseases and Treatments (2 papers). Mona Kargar collaborates with scholars based in Iran, United States and Canada. Mona Kargar's co-authors include Kheirollah Gholami, Hossein Khalili, Shahin Akhondzadeh, Padideh Ghaeli, Alireza Ahmadvand, Molouk Hadjibabaie, Mohammadreza Javadi, Majid Sadeghi, Ali Rafei and Molouk Hadjibabaie and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Epilepsia.

In The Last Decade

Mona Kargar

29 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mona Kargar Iran 11 99 92 58 43 42 32 364
Sarah McLeay Australia 11 80 0.8× 24 0.3× 11 0.2× 12 0.3× 70 1.7× 21 527
Luca Soraci Italy 12 22 0.2× 31 0.3× 32 0.6× 112 2.6× 69 1.6× 49 596
Stefania Antoniazzi Italy 13 60 0.6× 65 0.7× 5 0.1× 30 0.7× 83 2.0× 33 481
Cameron Wright Australia 11 38 0.4× 25 0.3× 25 0.4× 14 0.3× 105 2.5× 34 364
Laura E. Dowsett Canada 12 143 1.4× 16 0.2× 21 0.4× 6 0.1× 82 2.0× 14 404
Arijita Deb United States 9 15 0.2× 89 1.0× 8 0.1× 23 0.5× 107 2.5× 34 445
E. Paul Larrat United States 11 42 0.4× 41 0.4× 8 0.1× 132 3.1× 51 1.2× 19 360
Anita Siu United States 11 47 0.5× 24 0.3× 5 0.1× 8 0.2× 27 0.6× 23 357
Anders Westanmo United States 10 60 0.6× 29 0.3× 9 0.2× 18 0.4× 23 0.5× 26 314
Debra Farver United States 11 64 0.6× 79 0.9× 4 0.1× 4 0.1× 64 1.5× 28 402

Countries citing papers authored by Mona Kargar

Since Specialization
Citations

This map shows the geographic impact of Mona Kargar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Kargar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Kargar more than expected).

Fields of papers citing papers by Mona Kargar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Kargar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Kargar. The network helps show where Mona Kargar may publish in the future.

Co-authorship network of co-authors of Mona Kargar

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Kargar. A scholar is included among the top collaborators of Mona Kargar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Kargar. Mona Kargar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kargar, Mona, et al.. (2025). Modulatory effects of M3 muscarinic acetylcholine receptor on inflammatory profiles of human memory T helper cells. The Journal of Immunology. 214(9). 2244–2255. 1 indexed citations
2.
Kargar, Mona, et al.. (2024). Lipid management strategies for diabetic patients align with an evidence-based guideline. DARU Journal of Pharmaceutical Sciences. 32(2). 665–673.
5.
Amini, Shahideh, et al.. (2020). Is Inhaler Technique Associated with Quality of Life in Patients with Chronic Obstructive Pulmonary Disease?. Current Therapeutic Research. 93. 100608–100608. 6 indexed citations
6.
Kargar, Mona, et al.. (2018). Factors Affecting the Incidence and Severity of Oral Mucositis Following Hematopoietic Stem Cell Transplantation. PubMed Central. 19 indexed citations
7.
Mohammadpour, Fatemeh, Mona Kargar, & Molouk Hadjibabaie. (2018). The Role of Hydroxychloroquine as a Steroid-sparing Agent in the Treatment of Immune Thrombocytopenia: A Review of the Literature.. SHILAP Revista de lepidopterología. 7(1). 4–12. 9 indexed citations
8.
Hadjibabaie, Molouk, et al.. (2016). The risk factors for cytomegalovirus reactivation following stem cell transplantation. Journal of Research in Pharmacy Practice. 5(1). 63–63. 26 indexed citations
9.
Kargar, Mona, et al.. (2015). Comparing the Efficacy of 8 Weeks Treatment of Cipram® and its Generic Citalopram in Patients With Mixed Anxiety-Depressive Disorder. Iranian Journal of Psychiatry and Behavioral Sciences. 9(2). e230–e230. 3 indexed citations
10.
Kargar, Mona, et al.. (2015). Streptokinase Adverse Reactions: A Review of Iranian Literature. SHILAP Revista de lepidopterología. 2 indexed citations
11.
Kargar, Mona, et al.. (2014). Anti-tuberculosis drugs adverse reactions: a review of the Iranian literature. Expert Opinion on Drug Safety. 13(7). 875–891. 11 indexed citations
12.
Kargar, Mona, Alireza Ahmadvand, Molouk Hadjibabaie, et al.. (2013). The prevalence of antifungal agents administration in patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective study. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Ahmadvand, Alireza, et al.. (2013). Types and severity of medication errors in Iran; a review of the current literature. DARU Journal of Pharmaceutical Sciences. 21(1). 49–49. 47 indexed citations
15.
Lotfi, Mohsen, et al.. (2012). Virulence assessment of a Neospora caninum isolate for inbred C57BL/6 mouse. SHILAP Revista de lepidopterología.
16.
Hamidieh, Amir Ali, Mona Kargar, Kamran Alimoghaddam, et al.. (2012). The Outcome of Allogeneic Hematopoietic Stem Cell Transplants Without Total Body Irradiation in Pediatric Patients With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 34(2). 101–107. 14 indexed citations
17.
Nikbakht, Ali, Sayed Amir Hossein Goli, Mona Kargar, & Safoura Ahmadzadeh. (2011). Effect of humic acid on yield and oil characteristics of Silybum marianum and Cucurbita pepo convar. pepo var. styriaca seeds. Herba Polonica. 57(4). 6 indexed citations
18.
Hassanian‐Moghaddam, Hossein, et al.. (2010). Factors associated with nonbenzodiazepine antiepileptic drug intoxication: Analysis of 9,809 registered cases of drug poisoning. Epilepsia. 51(6). 979–983. 11 indexed citations
19.
Mansourian, Morteza, et al.. (2009). Knowledge and attitude of university students about ecstasy in Gorgan - Iran.. SHILAP Revista de lepidopterología. 10(428). 60–63. 4 indexed citations
20.
Aminlari, Mahmoud, et al.. (1994). The Cyanide-Metabolizing Enzyme Rhodanese in Different Parts of the Respiratory Systems of Sheep and Dog. Toxicology and Applied Pharmacology. 124(1). 67–71. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026